Your browser doesn't support javascript.
loading
Successful provision of CAR-T therapy during a pandemic: low SARS-CoV-2 infection rates and reduction in ICU admissions following modification of patient pathway.
Carter-Brzezinski, Luke; Davies, Elizabeth; Norman, Jane; Rubio, Lourdes; Dixon, Christopher; Brett, Sarah; Dunne, Tony; Iqbal, Shahid; Dignan, Fiona L; Ahmad, Shazaad; Machin, Nicholas; Morriss, Henry; Wilson, Anthony; Tholouli, Eleni.
Afiliação
  • Carter-Brzezinski L; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Davies E; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Norman J; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Rubio L; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Dixon C; Department of Critical Care Medicine, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Brett S; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Dunne T; Department of Critical Care Medicine, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Iqbal S; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Dignan FL; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Ahmad S; Department of Virology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Machin N; Department of Virology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Morriss H; Department of Critical Care Medicine, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Wilson A; Department of Critical Care Medicine, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
  • Tholouli E; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
Leuk Lymphoma ; 63(13): 3265-3267, 2022 12.
Article em En | MEDLINE | ID: mdl-35994619
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / COVID-19 Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / COVID-19 Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido